tiprankstipranks
Trending News
More News >
InDex Pharmaceuticals Holding AB (SE:FLERIE)
:FLERIE
US Market

InDex Pharmaceuticals Holding AB (FLERIE) Cash flow

Compare
1 Followers

InDex Pharmaceuticals Holding AB Cash Flow

SE:FLERIE's free cash flow for Q4 2025 was kr0.00. For the 2025 fiscal year, SE:FLERIE's free cash flow was decreased by kr17.00M and operating cash flow was kr-3.30M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
kr -28.10Mkr -17.00Mkr -37.98Mkr -129.44Mkr -124.06M
Investing Cash Flow
kr -109.50Mkr -19.80Mkr -625.20Mkr 0.00kr 0.00
Financing Cash Flow
kr -195.50Mkr 571.90Mkr 634.70Mkr -818.00Kkr 486.39M
End Cash Position
kr 540.20Mkr 865.10Mkr 294.27Mkr 344.93Mkr 428.45M
Free Cash Flow
kr 0.00kr -17.00Mkr -37.98Mkr -129.44Mkr -124.06M
Currency in SEK

InDex Pharmaceuticals Holding AB Cash Flow